RxDoctor Payments Data

Rasesh Shah, MD

Vascular Surgery · Chesapeake, VANPI 1639140056

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $366,231 of the $465,440 with a category attached, or 78.7%. Silk Road Medical, Inc. accounts for 95.2% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2022 at $102,735 and has fallen 86.6% since, to $13,723 in 2025. Among vascular surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$465,440in general payments, 2019–2025

Across 694 payments — averaging $670.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Silk Road Medical, Inc.$443K
  • Boston Scientific$13K
  • Medtronic$3K
  • W. L. Gore & Associates, Inc.$2K
  • Endologix LLC$637
  • Bard Peripheral Vascular, Inc.$629
  • plus $3K from 21 others
$109,164in research payments, 2019–2025

Across 22 payments — averaging $4961.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Silk Road Medical, Inc.$97K
  • Microvention, Inc.$8K
  • Boston Scientific$4K
  • W. L. Gore & Associates, Inc.$910

What the payments were for

  • Consulting fees$366,23179%
  • Speaking & faculty fees$15,1253%
  • Travel & lodging$61,13213%
  • Food & beverage$22,9375%
  • Education$140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$465,440 in reported general payments places this provider in the 95th percentile of 143 vascular surgery providers in Virginia.

See all vascular surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$289,809
Medicare patients
872
Services billed
1,550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate64$716
Atorvastatin Calcium28$156
Rosuvastatin Calcium17$106
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$59

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Chesapeake

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →